The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
2022 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to:Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Garg P, Maass F, Sundaram SM, Mollenhauer B, Mahajani S, van Riesen C, et al. The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease. Molecular and Cellular Neuroscience. 2022;121. doi:10.1016/j.mcn.2022.103746.
Documents & Media
Details
- Authors
- Garg, Pretty; Maass, Fabian; Sundaram, Sivaraj M.; Mollenhauer, Brit; Mahajani, Sameehan; van Riesen, Christoph; Kügler, Sebastian; Bähr, Mathias
- Issue Date
- 2022
- Journal
- Molecular and Cellular Neuroscience
- Project
- EXC 2067: Multiscale Bioimaging
- Working Group
- RG Bähr (Neurobiological Research Laboratory)
- External URL
- https://mbexc.uni-goettingen.de/literature/publications/496
- ISSN
- 1044-7431
- Language
- English
